Cargando…

Polyarticular arthritis as presenting feature of farber disease: a lysosomal storage disease involving inflammation

Detalles Bibliográficos
Autores principales:	Sólyom, Alexander, Karabul, Nesrin, Hügle, Boris, Simonaro, Calogera, Schuchman, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191560/ http://dx.doi.org/10.1186/1546-0096-12-S1-P285

Ejemplares similares

Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice
por: He, Xingxuan, et al.
Publicado: (2017)

New paradigms for the treatment of lysosomal storage diseases: targeting the endocannabinoid system as a therapeutic strategy
por: Schuchman, Edward H., et al.
Publicado: (2021)

Dose Responsive Effects of Subcutaneous Pentosan Polysulfate Injection in Mucopolysaccharidosis Type VI Rats and Comparison to Oral Treatment
por: Frohbergh, Michael, et al.
Publicado: (2014)

α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis
por: Zeller, Ludwig, et al.
Publicado: (2022)

Acid Ceramidase Protects Against Hepatic Ischemia/Reperfusion Injury by Modulating Sphingolipid Metabolism and Reducing Inflammation and Oxidative Stress
por: Jiang, Yuan, et al.
Publicado: (2021)

Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease
por: Crivaro, Andrea N., et al.
Publicado: (2019)

Enhanced chondrocyte apoptosis leads to abnormal cartilage in rats and cats with glycosaminoglycan storage diseases
por: Simonaro, CM, et al.
Publicado: (2001)

Home treatment for lysosomal diseases during COVID-19: German experience
por: Karabul, Nesrin, et al.
Publicado: (2021)

Farber disease: A clinical diagnosis
por: Ekici, Barış, et al.
Publicado: (2012)

Acid Sphingomyelinase Deficiency Ameliorates Farber Disease
por: Beckmann, Nadine, et al.
Publicado: (2019)

Classic Farber nudes
por: fFarber, Robert
Publicado: (1991)

Farber disease: report of three cases with joint involvement mimicking juvenile idiopathic arthritis
por: Moghadam, Soheila Hoseinzadeh, et al.
Publicado: (2019)

Acid ceramidase deficiency: Farber disease and SMA-PME
por: Yu, Fabian P. S., et al.
Publicado: (2018)

A case of Farber lipogranulomatosis.
por: Kim, Y. J., et al.
Publicado: (1998)

Farber Disease Mimicking Juvenile Idiopathic Arthritis: The First Reported Case in Qatar and Review of the Literature
por: Al-Naimi, Amal, et al.
Publicado: (2022)

Anti-TNF-Alpha Therapy Enhances the Effects of Enzyme Replacement Therapy in Rats with Mucopolysaccharidosis Type VI
por: Eliyahu, Efrat, et al.
Publicado: (2011)

Lyme arthritis of the pediatric lower extremity in the setting of polyarticular disease
por: Aiyer, Amiethab, et al.
Publicado: (2014)

Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients
por: Holzer, Marie-Therese, et al.
Publicado: (2022)

Polyarticular septic arthritis in an immunocompetent patient
por: Clements, J, et al.
Publicado: (2013)

Polyarticular juvenile idiopathic arthritis – epidemiology and management approaches
por: Oberle, Edward J, et al.
Publicado: (2014)

Farber disease: clinical presentation, pathogenesis and a new approach to treatment
por: Ehlert, Karoline, et al.
Publicado: (2007)

C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease
por: Cozma, Claudia, et al.
Publicado: (2017)

Lysosomes and Lysosomal Storage Diseases
por: Noebels, Jeffrey L.
Publicado: (1981)

Advances in the treatment of polyarticular juvenile idiopathic arthritis
por: Webb, Kate, et al.
Publicado: (2015)

Polyarticular tuberculosis: A rheumatoid arthritis mimic
por: Kumar, Dunga Sai, et al.
Publicado: (2020)

Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology
por: Sands, Mark S
Publicado: (2013)

Safety Study of Sodium Pentosan Polysulfate for Adult Patients with Mucopolysaccharidosis Type II
por: Orii, Kenji, et al.
Publicado: (2019)

Lysosomal storage diseases
por: Ferreira, Carlos R., et al.
Publicado: (2017)

A Case of Polyarticular Pasteurella multocida Septic Arthritis
por: Nitoslawski, Sarah, et al.
Publicado: (2016)

Polyarticular Haemophilus Influenza Septic Arthritis in an HIV Patient
por: Faruqi, Taha, et al.
Publicado: (2021)

Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review
por: Chaplin, Hema, et al.
Publicado: (2021)

Pompe disease: Shared and unshared features of lysosomal storage disorders
por: Lim, Jeong-A, et al.
Publicado: (2015)

A new definition of burnout syndrome based on Farber's proposal
por: Montero-Marín, Jesús, et al.
Publicado: (2009)

Biomarkers in Lysosomal Storage Diseases
por: Bobillo Lobato, Joaquin, et al.
Publicado: (2016)

Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations
por: McIntosh, Sydney Moore, et al.
Publicado: (2023)

Radiological cervical spine involvement in polyarticular idiopathic juvenile arthritis
por: Wipff, J, et al.
Publicado: (2011)

Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
por: Bakry, Reima, et al.
Publicado: (2022)

Polyarticular juvenile idiopathic arthritis (pJIA): clinical and serologic predictors of inactive disease (ID)
por: Meiorin, Silvia
Publicado: (2014)

Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis
por: Soulsby, William Daniel, et al.
Publicado: (2022)

Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses
por: Schuchman, Edward H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g6g24veqfiuenljhlcouliiq02